The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis

PlA1/PlA2 polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty

(2013) Monica Verdoia et al.   BLOOD COAGULATION & FIBRINOLYSIS

The impact of CYP3A5*1/*3, PIA1/A2 and T744C polymorphisms on clopidogrel and acetylsalicylic acid response variability in Mexican population

(2012) Irma Isordia-Salas et al.   THROMBOSIS RESEARCH

Genetic determinants of response to aspirin: Appraisal of 4 candidate genes

(2011) Marie Lordkipanidzé et al.   THROMBOSIS RESEARCH

The GPIIIa PlA polymorphism and the platelet hyperactivity in Tunisian patients with stable coronary artery disease treated with aspirin

(2010) Fatma Abderrazek et al.   THROMBOSIS RESEARCH

High loading dose of clopidogrel is unable to satisfactorily inhibit platelet reactivity in patients with glycoprotein IIIA gene polymorphism: a genetic substudy of PRAGUE-8 trial

(2009) Zuzana Motovska et al.   BLOOD COAGULATION & FIBRINOLYSIS

Impact of genetic polymorphisms on platelet function and aspirin resistance

(2009) Burak Pamukcu et al.   BLOOD COAGULATION & FIBRINOLYSIS

Association of Cyclooxygenase-1-Dependent and -Independent Platelet Function Assays With Adverse Clinical Outcomes in Aspirin-Treated Patients Presenting for Cardiac Catheterization

(2009) Andrew L. Frelinger et al.   CIRCULATION

Stroke and aspirin non-responder patients: Relation with hypertension and platelet response to adenosine diphosphate

(2009) G. Godeneche et al.   PLATELETS

Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations inP2RY12, P2RY1,andITGB3

(2009) Robert F. Storey et al.   PLATELETS

Pharmacogenetics of aspirin resistance: a comprehensive systematic review

(2008) Timothy Goodman et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY